New Insights into Microscopy

Watch the recording of our free webinar.

Discover the new ZEISS Axioscan 7 clinical

Your digital slide scanner for diagnostics & clinical research.

The New Precise Magazine is Available Now

Download the new issue.

ZEISS introduces the new Smartzoom 100

The future of digital microscopy for efficient optical inspections.

Smartzoom 100 – The New Digital Microscope for Maximum Efficiency

Free webinar July 1, 9:00-9:45 AM CEST and 5:00-5:45 PM CEST.

Positive EMA Decision for BioArctic's New Drug Candidate

Bioarctic's drug candidate for multiple system atrophy, exidavnemab, is recommended to be classified as an orphan drug, according to the European Medicines Agency (EMA).

De fick Swecares exportpris

Två företag mottog priser under Swecares årskonferens.

Explore the possibilities of the new ZEISS METROTOM 800 320 kV

Free ZEISS webinar July 10, 9:00-9:45 AM and 5:00-5:45 PM.

Trump in new push to lower drug prices

U.S. President Donald Trump announced on Sunday that he plans to sign an executive order to lower the cost of prescription drugs to the same levels paid in othe...

Pulsen på patientförbunden del 3: Reumatism

”Våra forskarkollegor har en vision om att reumatiska sjukdomar ska kunna förebyggas”, skriver Reumatikerförbundets ordförande Lotta Håkansson.

Pulsen på patientförbunden del 2: Postcovid

Trots att forskningen kring postcovid gjort stora framsteg på senare år är kunskapsluckorna många. Svenska Covidföreningen ser ett akut behov av fler läkemedels...

US Health Secretary Kennedy dismisses all vaccine experts – assembles new committee

Robert F. Kennedy Jr. has dismissed all 17 members of the CDC’s vaccine advisory panel. A new group of experts will be appointed directly by the Health Secretar...

Pulsen på patientförbunden del 4: Ung Cancer

”Engagemang och vilja finns, det gäller bara att hitta rätt former”, säger Therese Leijon, Ung Cancer, i Life Science Swedens artikelserie Pulsen på patientförbunden.

A new scientific event in Gothenburg

Life Science Sweden is holding an event in Gothenburg for the first time.

New drug to simplify treatment of hemophilia

A new type of treatment for hemophilia, which only needs to be administered every two months, has been approved by the U.S. Food and Drug Administration (FDA).

New moves around Nykode's management – withdrawal of resignations

Norwegian Nykode Therapeutics is reinstating members of the management team who previously announced their resignations.

The race between new alzheimer’s drugs Kisunla and Leqembi heats up

Kisunla or Leqembi? The rivalry between Eli Lilly and Bioarctic is intensifying. Where one drug gains approval, the other falls behind. Here's a look at the mar...

Pulsen på patientförbunden del 5: Hjärt- och lungsjukdomar

Sjukvården behöver ha ett ökat fokus på individens enskilda behov och samordna sig mer mellan specialist- och primärvård. Det framhåller Riksförbundet Hjärt Lun...

Mikael Kubista back with new venture after turbulent exit

Entrepreneur and researcher Mikael Kubista is starting a new company. Now he is also free to comment on the sequence of events that led to him losing ownership ...

GU Ventures AB

Agreement in the EU on eight years of data exclusivity for new medicines

New pharmaceuticals will be covered by eight years of data exclusivity, according to the proposed new pharmaceutical legislation that EU countries have now agre...

De vanligaste frågorna om ånga

Våra ångexperter har gjort en lista över de vanligaste frågorna om ånga och ångsystem. Läs svaren här och spara tid genom att inte behöva söka efter svaren.

One System, Three Contrasting Techniques

ZEISS Axioscan 7 clinical - your digital slide scanner for diagnostics and clinical research.

Alvotech i nytt miljardavtal om biosimilarer

Stockholmsnoterade Alvotech har ingått avtal med brittiska Advanz Pharma om kommersialisering av tre biosimilarkandidater.